Health
WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death – CNA
The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality.
GENEVA: The World Health Organization (WHO) said on Saturday (Jul 4) that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospit…
-
Noosa News15 hours agoMuster Dogs favourite Frank Finger makes final on-screen appearance with kelpie Annie in portrait show
-
Business13 hours agoShould we be paying more attention to these two rocketing ASX small-cap mining stocks?
-
Noosa News15 hours agoWhy commuters are less likely to see familiar strangers on the bus, train or CityCat and why that makes us feel less safe
-
General5 hours agoGoldfields man in coma after allegedly smashing head into ambulance windscreen